Group 1 - The core point of the article is that Zhongji Changshou Science (00767.HK) has extended the deadline for the memorandum of understanding regarding the acquisition of 100% equity in the Comprehensive Cell Bank Limited from October 2, 2025, to December 2, 2025, due to the need for additional time for due diligence and evaluation of the seller [1] - The target company is collaborating with Bright Cells Inc. in the United States on FDA-approved clinical research involving stem cells [1] - The collaboration aims to conduct clinical studies on mesenchymal stem cell treatments for aging and premature ovarian failure in regions including the United States, Hong Kong, Macau, Taiwan, Dubai, Malaysia, and Cambodia [1] Group 2 - If the acquisition is finalized, it may constitute a transaction that requires disclosure under the listing rules and could be considered a connected transaction [1]
中基长寿科学(00767.HK)延长收购亚洲综合细胞库有限公司股权谅解备忘录到期日